AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2017

Apr 11, 2017

34395_dirs_2017-04-11_fca8c580-375e-4239-8653-435d36bb6a9a.zip

Director's Dealing

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-04-10

Reporting Person: Vanston David Cecil (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned.	0	Direct